ICIG Wraps up Acquisition of Compounder Benvic

Following all approvals, International Chemical Investors (ICIG) has completed its acquisition of the compounds business of the French Benvic group. The closing follows a binding agreement signed in August.

Seller is PVC Europe Group, Luxembourg-based investment subsidiary of Investindustrial. (London). Benvic’s medical activities in Italy are planned to remain with the current owner.

Frankfurt, Germany-based strategic investor ICIG said it will integrate the Benvic compounding activities with more than 600 employees and annual sales of just under €500 million into a new group division called Compounds. The business will continue to operate under the Benvic branding and market approach.

Since its buyout, Benvic has been transformed into a “global leader in thermoplastic solutions,” thanks to a program of 10 add-on acquisitions across Europe and the US, Investindustrial said.“ This successful strategy,” the private equity investor said, allowed the plastics company to “significantly grow both sales and EBITDA and evolve from a niche compounder into a well-diversified platform poised for continued growth.”

© Investindustrial/Benvic
© Investindustrial/Benvic

Benvic has also consolidated its position as a “first mover and leader” on ESG matters, Industrialinvest added, by making contributions to the United Nation’s Sustainable Development Goals (SDGs). The compounder also completed an ESG-linked refinancing, as “one of the first of its kind in the European market” and also embraced the circular economy by developing sustainable and renewable materials.

The French compounder founded in 1963 as a subsidiary of Solvay, develops, produces and markets customized thermoplastic solutions based on PVC, engineering compounds and biopolymer that are used in a wide range of rigid and flexible end-applications. It has production facilities in France, Italy, Spain, Poland, the UK and the US.

Author: Dede Williams, Freelance Journalist

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.